论文部分内容阅读
目的:分析和评价主动脉内球囊反搏(IABP)在急性冠脉综合征(ACS)患者辅助治疗中的临床疗效。方法:60例ACS患者在不同的病情及治疗状况下,给予IABP治疗,观察使用IABP前后患者心率、血压及NT-proBNP的变化,注意IABP相关并发症,住院期间死亡情况。结果:60例患者接受IABP治疗后,血流动力学改善,其中合并心源性休克的患者在使用IABP后2 h后血压即达到稳定状态,72 h后NT-proBNP值明显下降。IABP相关并发症5例,严重并发症0例,住院期间死亡12例,其中合并心源性休克死亡9例。结论:对于ACS尤其是合并血流动力学不稳定或心源性休克的患者,IABP可以安全的使用,并有效地稳定血流动力学状态,为患者争取进行血运重建的时间,减少患者急性期的死亡率,改善预后。
Objective: To analyze and evaluate the clinical efficacy of intra-aortic balloon pump (IABP) in the adjuvant treatment of patients with acute coronary syndrome (ACS). Methods: 60 patients with ACS under different conditions and treatment conditions, given IABP treatment, before and after the use of IABP observed heart rate, blood pressure and NT-proBNP changes, pay attention to IABP-related complications, hospitalization during the death. Results: After IABP treatment, hemodynamics were improved in 60 patients. In patients with cardiogenic shock, blood pressure reached a steady state 2 hours after IABP administration, and NT-proBNP value decreased significantly after 72 hours. 5 cases of complications related to IABP, 0 cases of serious complications, 12 cases of death during hospitalization, of which 9 cases died of cardiogenic shock. CONCLUSIONS: IABP is safe for use in patients with ACS, especially those with unstable hemodynamics or cardiogenic shock, and is effective in stabilizing hemodynamic status, debilitating patients for revascularization and reducing acute patient The mortality rate, improve the prognosis.